Production of two protein-dependant cofactors (FAD and FMN) - Maintenance of normal metabolism - Energy and red blood cell maintenance
In every dose
30mg (equal to 7.5 pints of dairy milk or 150 cups of quinoa)
Vitamin B2 may have protective qualities against Parkinson’s disease, as sufferers have been shown to have significantly lower levels than healthy individuals. It could also be beneficial in reducing risk of Alzheimer’s.
What’s in it for my brain?
As its other B vitamin cohorts, Riboflavin contributes to a well functioning nervous system.
Essential for energy release from food
Protects eyes from free radical damage (antioxidant)
Plays well with
Riboflavin is available through diet, but mostly from animal sources, so those on a plant-based diet benefit from supplementation. To optimise the release of energy, it’s best consumed with other B vitamins. It’s also easily destroyed by the sun, so supplement for security.
A study of migraine-sufferers showed that daily supplementation of vitamin B2 cut migraine frequency in half.
Here’s a handful of relevant scientific studies on vitamin B2 (riboflavin).
Marashly, E. T., & Bohlega, S. A. (2017). Riboflavin has neuroprotective potential: focus on Parkinson’s disease and migraine. Frontiers in neurology, 8, 333.
Coimbra, C. G., & Junqueira, V. B. C. (2003). High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients. Brazilian journal of medical and biological research, 36(10), 1409-1417.
Maizels, M., Blumenfeld, A., & Burchette, R. (2004). A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache: The Journal of Head and Face Pain, 44(9), 885-890.
Shen, L. (2015). Associations between B vitamins and Parkinson’s disease. Nutrients, 7(9), 7197-7208.
Tavares, N. R., Moreira, P. A., & Amaral, T. F. (2009). Riboflavin supplementation and biomarkers of cardiovascular disease in the elderly. JNHA-The Journal of Nutrition, Health and Aging, 13(5), 441-446.
Chinthapalli, K. (2014). Alzheimer’s disease: still a perplexing problem. Bmj, 349.